Dermatan Sulfate

serpin family D member 1 ; Homo sapiens







72 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22987196 Alterations of fibrin network structure mediated by dermatan sulfate. 2013 Feb 4
2 21805439 Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis. 2011 Jun 1
3 20670608 Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli. 2010 Nov 15 4
4 18971786 Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction. 2008 Dec 1
5 16650906 Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events. 2007 Jan 8 2
6 17222891 Effect of oversulfated dermatan sulfate derivatives on platelet aggregation. 2007 2
7 16339402 Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. 2006 Apr 1 6
8 16624894 N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate. 2006 Aug 8
9 14744972 High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention. 2004 Feb 3 3
10 15078125 Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate. 2004 5
11 15148272 Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. 2004 Jun 8 3
12 15315969 Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice. 2004 Dec 15 2
13 12818259 Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans. 2003 Mar 15 1
14 12095635 Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition. 2002 Jul 3 4
15 12149217 Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. 2002 Aug 15 2
16 12413592 Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. 2002 Jul 15 1
17 10749870 Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. 2000 Jun 16 2
18 10753952 Activation of heparin cofactor II by calcium spirulan. 2000 Apr 14 2
19 10093889 A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding. 1999 Feb 12 2
20 10209287 Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions. 1999 Apr 12 4
21 10349131 [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role]. 1999 3
22 10488098 Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. 1999 Sep 24 7
23 10494755 Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis. 1999 Sep 2
24 9485475 Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex. 1998 Mar 3 2
25 9813026 Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes. 1998 Nov 20 1
26 9843172 Isolation of frog and chicken cDNAs encoding heparin cofactor II. 1998 Nov 2
27 9068899 Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative. 1997 Feb 1
28 9353333 Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II. 1997 Nov 7 2
29 8562924 Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji). 1996 Feb 1 2
30 8792767 Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. 1996 Sep 2
31 8815580 The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1. 1996 Feb 1
32 8885144 Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II. 1996 Oct 1 5
33 7908224 Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure. 1994 Mar 29 2
34 8017769 The interaction of glycosaminoglycans with heparin cofactor II. 1994 Apr 18 6
35 8091403 Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins. 1994 Jun 15 2
36 8181003 Dermatan sulfate from beef mucosa: structure, physicochemical and biological properties of fractions prepared by chemical depolymerization and anion-exchange chromatography. 1994 Mar 4 1
37 8259546 The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate. 1993 Sep 1 1
38 8335699 Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose. 1993 Jun 2 2
39 8429040 Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. 1993 Feb 15 1
40 1333106 The inhibition of thrombin and chymotrypsin by heparin-cofactor II. 1992 Oct 1 3
41 1381850 Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. 1992 Jun 1 2
42 1442260 The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide. 1992 6
43 1521342 An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials. 1992 Jan 31 2
44 1554154 Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate. 1992 Jan 1
45 1579900 Use of purified dermatan sulfate for heparin cofactor II (HC II) assay. 1992 Jan 15 2
46 1646210 Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification. 1991 Feb 22 8
47 1671335 Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. 1991 Feb 5 2
48 1831893 [Recurrent venous thromboembolism caused by heparin cofactor II deficiency. A case]. 1991 Jul 6-13 1
49 2028443 Heparin cofactor II: experimental approach to a new assay and clinical results. 1991 Feb 1 1
50 2045458 Purification of heparin cofactor II from human plasma. 1991 Feb 22 3